Hamel Associates, Inc. Medtronic PLC Transaction History

Hamel Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$69.43 - $83.43 $2.16 Million - $2.59 Million	-31,040 Reduced 82.89%	6,405 $527,000
Q3 2023 Nov 03, 2023	SELL	$78.22 - $90.4 $121,241 - $140,120	-1,550 Reduced 3.97%	37,445 $2.93 Million
Q2 2023 Aug 08, 2023	BUY	$79.47 - $91.38 $696,951 - $801,402	8,770 Added 29.02%	38,995 $3.44 Million
Q1 2023 May 08, 2023	BUY	$76.72 - $87.58 $2.32 Million - $2.65 Million	30,225 New	30,225 $2.44 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Hamel Associates, Inc. with notifications on news.